“COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial”, J of Skin, vol. 5, no. 6, p. s58, Nov. 2021, doi: 10.25251/skin.5.supp.58.